SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Olsson Caroline 1970 ) "

Sökning: WFRF:(Olsson Caroline 1970 )

  • Resultat 1-10 av 42
  • [1]2345Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Alevronta, Eleftheria, et al. (författare)
  • Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy.
  • 2013
  • Ingår i: Acta oncologica (Stockholm, Sweden). - 1651-226X. ; 52:4, s. 719-26
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose. The aim of this study was to investigate what bowel organ and delivered dose levels are most relevant for the development of 'emptying of all stools into clothing without forewarning' so that the related dose-responses could be derived as an aid in avoiding this distressing symptom in the future. Material and methods. Of the 77 gynecological cancer survivors treated with radiotherapy (RT) for gynecological cancer, 13 developed the symptom. The survivors were treated between 1991 and 2003. The anal-sphincter region, the rectum, the sigmoid and the small intestines were all delineated and the dose-volume histograms were exported for each patient. The dose-volume parameters were estimated fitting the data to the Relative Seriality (RS), the Lyman and the generalized Equivalent Uniform Dose (gEUD) model. Results. The dose-response parameters for all three models and four organs at risk (OARs) were estimated. The data from the sigmoid fits the studied models best: D50 was 58.8 and 59.5 Gy (RS, Lyman), γ50 was 1.60 and 1.57 (RS, Lyman), s was 0.32, n was 0.13 and a was 7.7 (RS, Lyman, gEUD). The estimated volume parameters indicate that the investigated OARs behave serially for this endpoint. Our results for the three models studied indicate that they have the same predictive power (similar LL values) for the symptom as a function of the dose for all investigated OARs. Conclusions. In our study, the anal-sphincter region and sigmoid fit our data best, but all OARs were found to have steep dose-responses for 'emptying of all stools into clothing without forewarning' and thus, the outcome can be predicted with an NTCP model. In addition, the dose to the four studied OARs may be considered when minimizing the risk of the symptom.
  •  
3.
  •  
4.
  • Alsadius, David, 1975-, et al. (författare)
  • Partnership status affects the association between gastrointestinal symptoms and quality of life after radiation therapy for prostate cancer.
  • 2014
  • Ingår i: Acta oncologica (Stockholm, Sweden). - 1651-226X. ; 53:3, s. 378-384
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose. To study if partnership modifies the effect of gastrointestinal symptoms on quality of life after radiation therapy for prostate cancer. Material and methods. Using a study-specific questionnaire we conducted a cross-sectional follow-up of the occurrence gastrointestinal symptoms and quality of life after radiation therapy for prostate cancer. We obtained information from 874 prostate cancer survivors treated with radiation therapy at the Sahlgrenska University Hospital, Sweden between 1994 and 2006. In this paper we describe how partnership status affects the association between gastrointestinal symptoms and quality of life. Results. We found that unpartnered men with gastrointestinal symptoms reported a lower quality of life than unpartnered men without such symptoms. Unpartnered men with symptoms had an excess risk of low quality of life compared with unpartnered men without symptoms for those experiencing altered composition of stools, prevalence ratio 3.8 (95% CI 1.1-13.1), leakage, 3.6 (1.3-10.1), sensory bowel symptoms, 4.5 (1.6-12.8), and for urgency, 4.2 (1.2-15.1). We also found that unpartnered men with symptoms had an excess risk of low quality of life compared with partnered men with symptoms for those experiencing altered composition of stools, prevalence ratio 2.9 (95% CI 1.4-5.8), leakage 2.8 (1.2-6.4), sensory bowel symptoms 3.4 (1.5-7.4), urgency 2.6 (1.2-5.8), and for any gastrointestinal symptom 2.5 (1.3-4.9). Conclusion. Unpartnered men may represent a group that is specifically vulnerable to the distressful effects of gastrointestinal symptoms after radiation therapy for prostate cancer.
  •  
5.
  • Alsadius, David, 1975-, et al. (författare)
  • Patient-reported gastrointestinal symptoms among long-term survivors after radiation therapy for prostate cancer.
  • 2014
  • Ingår i: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. - 1879-0887. ; 112:2
  • Tidskriftsartikel (refereegranskat)abstract
    • With modern radiotherapy technology we have the means to substantially reduce late gastrointestinal toxicities after radiation therapy for prostate cancer. However, there is still a lack of knowledge regarding the spectrum of patient-reported gastrointestinal symptoms after such treatment.
  •  
6.
  • Alsadius, David, 1975-, et al. (författare)
  • Perception of body odor-an overlooked consequence of long-term gastrointestinal and urinary symptoms after radiation therapy for prostate cancer.
  • 2013
  • Ingår i: Journal of cancer survivorship : research and practice. - 1932-2267. ; 7:4, s. 652-658
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose This study was conducted to investigate the association of long-term gastrointestinal and urinary symptoms with perceived fecal or urine body odor after radiation therapy for prostate cancer and its effect on survivors’ quality of life. Methods We used a study-specific questionnaire to measure the occurrence of long-term gastrointestinal and urinary symptoms, the perception of fecal or urine body odor, and quality of life (QoL) 2 to 14 years after radiation therapy for prostate cancer. The questionnaire was sent to 895 eligible survivors who assessed symptom occurrence and QoL in the previous 6 months. Results We received a filled-in questionnaire from 874 (89 %) men. For the long-term gastrointestinal symptoms, 11/13 were associated with the perception of fecal body odor. For the long-term urinary symptoms, 11/11 were associated with the perception of urine body odor. Men who perceived fecal or urine body odor had a lower quality of life, a lower physical health, and more frequent feelings of depression compared with those who did perceive such body odor. Conclusion Long-term gastrointestinal and urinary symptoms after prostate irradiation are associated with the perception of fecal or urine body odor leading to a reduced quality of life. Implications for cancer survivors Disabling body odor after pelvic irradiation needs to be acknowledged in the clinic. Interventions to prevent long-term symptoms may serve the benefit of avoiding fecal or urine body odor after radiation therapy for prostate cancer.
  •  
7.
  • Jernås, Margareta, 1961-, et al. (författare)
  • MS risk genes are transcriptionally regulated in CSF leukocytes at relapse
  • 2013
  • Ingår i: Multiple sclerosis (Houndmills, Basingstoke, England). - 1477-0970. ; 19:4, s. 403-410
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Infiltrating T-helper cells, cytotoxic T-cells, B-cells and monocytes are thought to mediate the damage to myelin, oligodendrocytes and axons in multiple sclerosis (MS), which results in progressive disability. OBJECTIVE: The objective of this paper is to explore gene expression profiles of leukocytes in the cerebrospinal fluid (CSF) compartment of MS patients during relapse. METHODS: Global gene expression was analyzed by DNA microarray analysis of cells in CSF from MS patients and controls, and verifications were performed with real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). RESULTS: Fifty percent of the recently described risk genes for MS and 28% of non-risk genes were differently expressed in MS patients compared to controls (χ(2)-test, p=7.7 × 10(-5)). Genes involved in T- and NK-cell processes were up-regulated, and genes involved in processes targeting innate immunity or B-cells were down-regulated in MS. Increased expression of EDN1 and CXCL11 and decreased expression of HMOX1 was verified with real-time PCR and increased expression of CXCL13 was verified with ELISA in CSF. CONCLUSION: DNA microarray analysis is useful in identifying differently expressed genes in CSF leukocytes, which may be important in MS in vivo. Our findings suggest that many of the risk genes for MS are differently expressed in the disease-mediating leukocytes that penetrate the blood-brain barrier.
  •  
8.
9.
  •  
10.
  • Oh, J. H., et al. (författare)
  • A Factor Analysis Approach for Clustering Patient Reported Outcomes
  • 2016
  • Ingår i: Methods of Information in Medicine. - 0026-1270. ; 55:5, s. 431-439
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: In the field of radiation oncology, the use of extensive patient reported outcomes is increasingly common to measure adverse side effects after radiotherapy in cancer patients. Factor analysis has the potential to identify an optimal number of latent factors (i.e., symptom groups). However, the ultimate goal of treatment response modeling is to understand the relationship between treatment variables such as radiation dose and symptom groups resulting from FA. Hence, it is crucial to identify clinically more relevant symptom groups and improved response variables from those symptom groups for a quantitative analysis. Objectives: The goal of this study is to design a computational method for finding clinically relevant symptom groups from PROs and to test associations between symptom groups and radiation dose. Methods: We propose a novel approach where exploratory factor analysis is followed by confirmatory factor analysis to determine the relevant number of symptom groups. We also propose to use a combination of symptoms in a symptom group identified as a new response variable in linear regression analysis to investigate the relationship between the symptom group and dose-volume variables. Results: We analyzed patient-reported gastrointestinal symptom profiles from 3 datasets in prostate cancer patients treated with radiotherapy. The final structural model of each dataset was validated using the other two datasets and compared to four other existing FA methods. Our systematic EFA-CFA approach provided clinically more relevant solutions than other methods, resulting in new clinically relevant outcome variables that enabled a quantitative analysis. As a result, statistically significant correlations were found between some dose volume variables to relevant anatomic structures and symptom groups identified by FA. Conclusions: Our proposed method can aid in the process of understanding PROs and provide a basis for improving our understanding of radiation-induced side effects.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 42
  • [1]2345Nästa
Åtkomst
fritt online (1)
Typ av publikation
tidskriftsartikel (35)
konferensbidrag (4)
forskningsöversikt (1)
doktorsavhandling (1)
licentiatavhandling (1)
Typ av innehåll
refereegranskat (35)
övrigt vetenskapligt (7)
Författare/redaktör
Olsson, Caroline, 19 ... (39)
Steineck, Gunnar, 19 ... (19)
Steineck, G, (18)
Olsson, C (13)
Alsadius, David, 197 ... (12)
Wilderäng, Ulrica, (11)
visa fler...
Pettersson, Niclas, (11)
Alsadius, D (11)
Pettersson, N (11)
Wilderang, U (10)
Johansson, Karl-Axel ... (9)
Waldenström, Ann-Cha ... (8)
Johansson, KA (7)
Waldenstrom, AC (7)
Björk-Eriksson, Thom ... (6)
al-Abany, M, (6)
Lind, H. (6)
Dunberger, G, (6)
Avall-Lundqvist, E, (6)
Dunberger, Gail (6)
Finizia, Caterina, 1 ... (5)
al-Abany, Massoud (5)
Alevronta, E, (5)
Nyberg, T, (4)
Alevronta, Eleftheri ... (4)
Lind, Helena, (4)
Nyberg, Tommy (3)
Avall-Lundqvist, Eli ... (3)
Tucker, Susan L (3)
Tucker, SL (3)
Tucker, S L (3)
Olsson, Malin, (2)
Myrelid, Pär, (2)
Blennow, Kaj, 1958-, (2)
Tuomi, Lisa, 1985-, (2)
Zetterberg, Henrik, ... (2)
Halfvarson, Jonas, 1 ... (2)
Lind, Bengt K, (2)
Lind, BK (2)
Olsson, Bob, 1969-, (2)
Karling, Pontus, (2)
Åvall-Lundqvist, Eli ... (2)
Bergmark, Karin, (2)
Hjortswang, Henrik, (2)
Grip, Olof (2)
Bengtsson, Jonas, (2)
Andersson, Marie, (2)
Olen, Ola (2)
Ludvigsson, Jonas F. ... (2)
Hoyer, M (2)
visa färre...
Lärosäte
Göteborgs universitet (39)
Karolinska Institutet (18)
Chalmers tekniska högskola (6)
Örebro universitet (2)
Umeå universitet (1)
Språk
Engelska (42)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (42)
Naturvetenskap (2)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy